Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Delic Holdings Corp (DELCF) Message Board

DEA Delay Leaves Synthetic Psychedelics in Legal L

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 135
(Total Views: 227)
Posted On: 08/26/2022 7:07:11 PM
Avatar
Posted By: NetworkNewsWire
DEA Delay Leaves Synthetic Psychedelics in Legal Limbo

Psychedelics are currently experiencing a renaissance that has been characterized by a significant surge in scientific research, public interest and reform efforts. Said to be effective against mental health conditions such as eating disorders, anxiety, depression and post-traumatic stress disorder, psychedelics have been subject to several legislative efforts across the country as activists have tried to get them legalized for medical use.

There are a wide variety of psychedelics, including a class of artificial psychedelics that are synthesized in a laboratory rather than extracted from a natural source.

In 2021, the U.S. Drug Enforcement Agency (DEA) announced that it was planning on classifying five little-known psychedelics as Schedule I drugs, outlawing their development, purchase and use, and making it almost impossible to research them. However, the DEA backed down on its decision to criminalize the five obscure psychedelics in late July and sent the hallucinogenic compounds back to the Department of Health and Human Service for review.

While the DEA’s decision was a major win for companies that are focused on psychedelics research and development, it is still a temporary victory. The long-term fate of these mind-altering drugs continues to hang in the balance, and regulators are still considering how to handle artificial or designer psychedelics that are designed to mimic the effects of natural psychedelics such as psilocybin.

Even though these drugs have the potential to become alternative mental health treatments, and generate millions of dollars for the companies that develop these treatments, we still have plenty to learn about psychedelics and how their use can affect public health.

Matthew Baggot, CEO of Tactogen, a company that focuses on designer chemicals that resemble MDMA, stated that the entire psychedelic research space would become a lot more expensive and advance slowly if the DEA rescheduled the five psychedelics. After all, it is federal prohibition that has basically made it impossible to research psychedelics in the past couple of decades.

Now that more states are loosening their psychedelic policies, criminalizing the substances could set back psychedelics research by decades. Baggot, who has overseen Tactogen as it researches hundreds of chemicals that are similar to MDMA, was prepared to testify at the DEA hearing because some of the chemicals the company studies would have been affected by the DEA’s proposed ban.

This is because the ban would have impacted dozens of chemicals, not just the five psychedelics the DEA was looking to ban: 5-MeO-AMT, 5-MeO-MiPT, 5-MeO-DET, DiPT, and 4-OH-DiPT. Now that the DEA has shelves its plan to schedule the five psychedelics, the industry eagerly awaits a legislative decision from the government.

This regulatory gray area could in some way hamper the progress of psychedelics industry actors such as Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) that depend on regulatory certainty to plan their future development programs.

NOTE TO INVESTORS: The latest news and updates relating to Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) are available in the company’s newsroom at https://ibn.fm/DELCF

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer




(0)
(0)




Delic Holdings Corp (DELCF) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us